Product Information

BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0217 per EA under NDC 00904712261. Its NADAC has been published 231 times since Mar 23, 2022.

FDA first approved this application on Sep 18, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Buspirone Hydrochloride market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 23.8%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.